




Searching News Database: malaria
HSMN NewsFeed - 27 Dec 2021
VLP Therapeutics raises $21M Series A-1 for cancer treatment vaccine, infectious diseases vaccine R&D
VLP Therapeutics raises $21M Series A-1 for cancer treatment vaccine, infectious diseases vaccine R&D
HSMN NewsFeed - 23 Mar 2021
Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board
Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board
HSMN NewsFeed - 13 Jul 2018
Modus Therapeutics Completes a SEK 140 Million Financing led by HealthCap
Modus Therapeutics Completes a SEK 140 Million Financing led by HealthCap
HSMN NewsFeed - 11 Jun 2018
Roche introduces first self-testing device for Warfarin monitoring with built in Bluetooth(R) technology
Roche introduces first self-testing device for Warfarin monitoring with built in Bluetooth(R) technology
HSMN NewsFeed - 16 Apr 2018
Roche receives FDA clearance for cobas(R) CT/NG for cobas(R) 6800/8800 Systems
Roche receives FDA clearance for cobas(R) CT/NG for cobas(R) 6800/8800 Systems
HSMN NewsFeed - 8 Mar 2018
Roche launches the new cobas m 511 analyzer, signaling a new era in hematology testing
Roche launches the new cobas m 511 analyzer, signaling a new era in hematology testing
HSMN NewsFeed - 26 Jul 2017
Roche Launches the Avenio Millisect System for Precise and Efficient Dissection of Tissue Biopsies
Roche Launches the Avenio Millisect System for Precise and Efficient Dissection of Tissue Biopsies
HSMN NewsFeed - 12 Apr 2017
Roche Launches Antibody Test to Aid in Diagnosis of Challenging Prostate Cancer Cases
Roche Launches Antibody Test to Aid in Diagnosis of Challenging Prostate Cancer Cases
HSMN NewsFeed - 22 Sep 2016
Sanaria(R) PfSPZ Vaccine Against Malaria Receives FDA Fast Track Designation
Sanaria(R) PfSPZ Vaccine Against Malaria Receives FDA Fast Track Designation
HSMN NewsFeed - 25 May 2016
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
HSMN NewsFeed - 21 Mar 2016
FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis
FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis
HSMN NewsFeed - 21 Dec 2015
Roche receives FDA approval for HIV-1 viral load test on the cobas(R) 6800/8800 Systems
Roche receives FDA approval for HIV-1 viral load test on the cobas(R) 6800/8800 Systems
HSMN NewsFeed - 1 Dec 2015
Roche And Upsher-Smith Announce License Agreement To Develop Novel VAP-1 Inhibitor
Roche And Upsher-Smith Announce License Agreement To Develop Novel VAP-1 Inhibitor
HSMN NewsFeed - 26 May 2015
Roche receives FDA clearance for the cobas(R) Cdiff Test to detect Clostridium difficile
Roche receives FDA clearance for the cobas(R) Cdiff Test to detect Clostridium difficile
HSMN NewsFeed - 29 Dec 2014
Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test
Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test
HSMN NewsFeed - 24 Apr 2014
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
HSMN NewsFeed - 1 Apr 2014
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality
HSMN NewsFeed - 5 Sep 2013
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
HSMN NewsFeed - 29 Apr 2013
Dave Lemus Promoted to Chief Executive Officer of Sigma-Tau Pharmaceuticals, Inc.
Dave Lemus Promoted to Chief Executive Officer of Sigma-Tau Pharmaceuticals, Inc.
HSMN NewsFeed - 29 Oct 2012
Sigma-Tau Pharmaceuticals, Inc. Announces Appointment of New Vice President of Commercial Operations
Sigma-Tau Pharmaceuticals, Inc. Announces Appointment of New Vice President of Commercial Operations
HSMN NewsFeed - 6 Sep 2011
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
HSMN NewsFeed - 31 Aug 2011
Selecta Biosciences Appoints Takashi Kei Kishimoto, Ph.D., as Chief Scientific Officer
Selecta Biosciences Appoints Takashi Kei Kishimoto, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 20 Jun 2011
Genocea Biosciences Hires Ravi Venkataramani, Ph.D. as Vice President, Business Development
Genocea Biosciences Hires Ravi Venkataramani, Ph.D. as Vice President, Business Development
HSMN NewsFeed - 20 Apr 2011
Cerus Appoints William "Obi" Greenman as President and Chief Executive Officer
Cerus Appoints William "Obi" Greenman as President and Chief Executive Officer
HSMN NewsFeed - 1 Feb 2011
Genocea Biosciences Announces Promotion of Chip Clark to President and Chief Executive Officer
Genocea Biosciences Announces Promotion of Chip Clark to President and Chief Executive Officer
HSMN NewsFeed - 6 Jul 2010
Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer
Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer
HSMN NewsFeed - 19 May 2010
GenVec Announces Resignation of Mark Thornton as Senior Vice President, Product Development
GenVec Announces Resignation of Mark Thornton as Senior Vice President, Product Development
HSMN NewsFeed - 18 May 2010
AccuVein Signs Exclusive Distribution Agreement in India to Sell Vein Illumination Device
AccuVein Signs Exclusive Distribution Agreement in India to Sell Vein Illumination Device
HSMN NewsFeed - 6 May 2010
Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
HSMN NewsFeed - 6 May 2009
VaxInnate Corporation Closes $30 Million Round of Financing; Wellcome Trust Leads Round
VaxInnate Corporation Closes $30 Million Round of Financing; Wellcome Trust Leads Round
HSMN NewsFeed - 26 Mar 2009
Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
HSMN NewsFeed - 19 Nov 2008
GenVec Announces Interim Survival Data in Pivotal Trial of TNFerade in Locally Advanced Pancreatic Cancer
GenVec Announces Interim Survival Data in Pivotal Trial of TNFerade in Locally Advanced Pancreatic Cancer
HSMN NewsFeed - 11 Nov 2008
TNFerade(TM) Receives FDA Fast Track Designation for Treatment of Pancreatic Cancer
TNFerade(TM) Receives FDA Fast Track Designation for Treatment of Pancreatic Cancer
HSMN NewsFeed - 17 Apr 2008
Eisai Corporation of North America Announces Appointment of Vice President of U.S. Corporate Communications
Eisai Corporation of North America Announces Appointment of Vice President of U.S. Corporate Communications
HSMN NewsFeed - 4 Oct 2007
Dr. Martin Mackay Named President of Pfizer Global Research and Development
Dr. Martin Mackay Named President of Pfizer Global Research and Development
HSMN NewsFeed - 25 Sep 2007
SpectraScience Appoints the Honorable Tommy Thompson to its Board of Directors
SpectraScience Appoints the Honorable Tommy Thompson to its Board of Directors
HSMN NewsFeed - 6 Aug 2007
Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009
Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009
HSMN NewsFeed - 12 Jul 2007
Xechem International Announces Change in Its CEO; Offers Update on Nigerian Operations
Xechem International Announces Change in Its CEO; Offers Update on Nigerian Operations
HSMN NewsFeed - 22 Jun 2007
FDA Approves Carnitor(R) SF (Levocarnitine) Sugar-Free Oral Solution For Patients With Carnitine Deficiency
FDA Approves Carnitor(R) SF (Levocarnitine) Sugar-Free Oral Solution For Patients With Carnitine Deficiency
HSMN NewsFeed - 12 Jun 2007
Immtech and Par Enter Licensing Agreement on Pafuramidine for Treatment of Pneumocystis Pneumonia
Immtech and Par Enter Licensing Agreement on Pafuramidine for Treatment of Pneumocystis Pneumonia
HSMN NewsFeed - 23 Apr 2007
Inverness Medical Innovations to Acquire Indian Distributor Spectral Diagnostics
Inverness Medical Innovations to Acquire Indian Distributor Spectral Diagnostics
HSMN NewsFeed - 19 Apr 2007
Merck KGaA and WHO Conclude Partnership to Control Schistosomiasis in Africa
Merck KGaA and WHO Conclude Partnership to Control Schistosomiasis in Africa
HSMN NewsFeed - 27 Mar 2007
Corum Medical Signs Licensing Agreement with Brown University and Rhode Island Hospital
Corum Medical Signs Licensing Agreement with Brown University and Rhode Island Hospital
HSMN NewsFeed - 21 Feb 2007
Abaxis Receives Piccolo Xpress Order From Family Health International (FHI)
Abaxis Receives Piccolo Xpress Order From Family Health International (FHI)
HSMN NewsFeed - 12 Feb 2007
AVANT Immunotherapeutics and Select Vaccines Announce Partnership to Develop Improved Viral Vaccines
AVANT Immunotherapeutics and Select Vaccines Announce Partnership to Develop Improved Viral Vaccines
HSMN NewsFeed - 26 Jan 2007
GenVec Announces First Patient Treated with TNFerade(TM) for Head and Neck Cancer at University of Chicago
GenVec Announces First Patient Treated with TNFerade(TM) for Head and Neck Cancer at University of Chicago
HSMN NewsFeed - 11 Jan 2007
GenVec Receives Clearance From FDA for EUS Administration of TNFerade(TM)
GenVec Receives Clearance From FDA for EUS Administration of TNFerade(TM)
HSMN NewsFeed - 21 Nov 2006
US FDA Grants Immtech's Oral Drug Candidate Pafuramidine (DB289) Orphan Drug Status for Treatment of PCP
US FDA Grants Immtech's Oral Drug Candidate Pafuramidine (DB289) Orphan Drug Status for Treatment of PCP
HSMN NewsFeed - 12 Jul 2006
Mutual Pharmaceutical Company/AR Scientific Launches QUALAQUIN(TM) (quinine sulfate capsules USP, 324 mg)
Mutual Pharmaceutical Company/AR Scientific Launches QUALAQUIN(TM) (quinine sulfate capsules USP, 324 mg)
HSMN NewsFeed - 3 May 2006
Immtech Pharmaceuticals Announces Retirement of T. Stephen Thompson, President and Board Member
Immtech Pharmaceuticals Announces Retirement of T. Stephen Thompson, President and Board Member
Additional items found! 62

Members Archive contains
62 additional stories matching:
malaria
(Password required)
malaria
(Password required)